Pronota secures biomarker renal Dx patent; Depression biomarkers closer to reality;

> Belgium's Pronota has nailed down a crucial patent for the use of the LG3 blood biomarker in diagnosing renal failure, despite a previous U.S. Supreme Court decision questioning the practice. Item

> The Biomarker Europe Summit 2013 is scheduled for Oct. 9-10 in Berlin, Germany and will cover the latest biomarker discovery, translation and commercialization efforts. Item

> Scientists are getting much closer to developing diagnostic tests for depression biomarkers. Story

> The Biomarker France project proved genetic tumor profiling is feasible in patients with non-small-cell lung cancer and has already helped treat patients. Story

> An Arizona State University biochemist is probing the use of glycans as a possible lung cancer biomarker. Item

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.